The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be replaced with the “Mounjaro economy” now that Eli Lilly is controlling 60% ...

A federal judge on Wednesday dismissed part of Eli Lilly's lawsuit against the Houston-based Empower Pharmacy — the latest development in the pharmaceutical giant's bid to curb sales of cheaper, ...

Eli Lilly remains well-positioned in the obesity treatment market despite early script underperformance of Foundayo versus Novo Nordisk's oral Wegovy. LLY's long-term advantage lies in small molecule ...

Eli Lilly (LLY 1.16%) became the first healthcare company to reach $1 trillion in market cap last year. However, given its poor start to 2026, it has fallen well below that. Entering trading on Monday ...

A GLP-1 weight loss pill, already on sale in the United States, has hit a regulatory snag. The Food and Drug Administration has asked U.S. drugmaker Eli Lilly to collect more long-term safety data on ...

April 9 (UPI) --Eli Lilly announced that its GLP-1 weight-loss pill is available for purchase in the United States starting Thursday, little more than a week after the Food and Drug Administration ...

Beginning April 9, eligible patients can access Foundayo through Amazon Pharmacy, GoodRx, Ro, Weight Watchers and other providers. (Photo by Scott Olson/Getty Images) Eli Lilly has rolled out Foundayo ...

The consensus one-year price target sits at $1,209.21, implying significant upside from the current price of $935.58. The analyst breakdown: 24 Buy ratings, 6 Hold, and just 1 Sell. Lilly’s 2026 ...

A still from Eli Lilly's "150 Years of Everything Else" film. (Eli Lilly) Eli Lilly has published a video about how medicines affect lives to mark its 150th anniversary and the arrival of college ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA approval of the GLP-1 ...

Foundayo, a once-daily oral GLP-1 medication approved for obesity and weight-related issues, ranges in cost from $25 to $349 per month Scott Olson/Getty Drugmaker Eli Lilly has been approved to sell a ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.